Position in ABBV
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$1,631,382
+$223,352 QoQ
Shares Held
6,483
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#2,118
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Archer Investment Corp holds $22,689,953 across 14 Drug Manufacturers - General names. ABBV ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,262 | $9,909,691 | |
| 2 | JNJ |
Johnson & Johnson
|
15,648 | $3,974,122 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,453 | $2,756,710 | |
| 4 | PFE |
Pfizer Inc
|
73,546 | $1,770,987 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
6,483 | $1,631,382 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
24,272 | $1,398,552 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,578 | $957,404 | |
| 8 | SNY |
Sanofi
|
4,072 | $173,711 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,631,382 | 6,483 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $1,408,030 | 6,474 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,515,345 | 6,632 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,876,400 | 8,104 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,630,114 | 8,782 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,840,842 | 8,786 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,431,018 | 8,053 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,562,659 | 7,913 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,360,839 | 7,934 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,369,938 | 7,523 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,187,380 | 7,662 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,140,159 | 7,649 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,029,067 | 7,638 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,489,790 | 9,348 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,445,116 | 8,942 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,196,213 | 8,913 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,363,430 | 8,902 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,438,239 | 8,872 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,213,319 | 8,961 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $956,806 | 8,870 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $993,372 | 8,819 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $953,851 | 8,814 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $944,420 | 8,814 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $794,616 | 9,072 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $904,728 | 9,215 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $693,862 | 9,107 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||